Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Anabolic steroid–induced hypogonadism: diagnosis and treatment

Open access
Rahnema, Cyrus D., Lipshultz, Larry I., Crosnoe, Lindsey E., Kovac, Jason R., Kim, Edward D. · 2014 · Fertility and Sterility

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2014.02.002

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 97

  1. Borell, 1985, Organotherapy and the emergence of reproductive endocrinology, J Hist Biol, 18, 1, 10.1007/BF00127955 · DOI
  2. Brown-Séquard, 1893, On a new therapeutic method consisting in the use of organic liquids extracted from glands and other organs, Br Med J, 1, 1145, 10.1136/bmj.1.1692.1145 · doi:10.1136/bmj.1.1692.1145
  3. Brown-Séquard, 1889, The effects produced on man by subcutaneous injection of a liquid obtained from the testicles of animals, Lancet, 137, 105, 10.1016/S0140-6736(00)64118-1 · DOI · Paper page
  4. Foss, 1959, Oral methyltestosterone and jaundice, Br Med J, 1, 259, 10.1136/bmj.1.5117.259 · doi:10.1136/bmj.1.5117.259
  5. Foss, 1960, Some experiences with a new anabolic steroid (methandrostenolone), Br Med J, 1, 1300, 10.1136/bmj.1.5182.1300 · doi:10.1136/bmj.1.5182.1300
  6. Moss, 2013, Effect of rejuvenation hormones on spermatogenesis, Fertil Steril, 99, 1814, 10.1016/j.fertnstert.2013.04.003 · DOI
  7. Hartgens, 2004, Effects of androgenic-anabolic steroids in athletes, Sports Med, 34, 513, 10.2165/00007256-200434080-00003 · DOI · Paper page
  8. Kicman, 2008, Pharmacology of anabolic steroids, Br J Pharmacol, 154, 502, 10.1038/bjp.2008.165 · DOI · Paper page
  9. Parkinson, 2006, Anabolic androgenic steroids: a survey of 500 users, Med Sci Sports Exerc, 38, 644, 10.1249/01.mss.0000210194.56834.5d · DOI · Paper page
  10. Shahidi, 2001, A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids, Clin Ther, 23, 1355, 10.1016/S0149-2918(01)80114-4 · DOI · Paper page
  11. Casavant, 2007, Consequences of use of anabolic androgenic steroids, Pediatr Clin North Am, 54, 677, 10.1016/j.pcl.2007.04.001 · DOI
  12. Gårevik, 2011, Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids, J Steroid Biochem Mol Biol, 127, 295, 10.1016/j.jsbmb.2011.08.005 · DOI
  13. Kanayama, 2008, Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?, Drug Alcohol Depend, 98, 1, 10.1016/j.drugalcdep.2008.05.004 · DOI · Paper page
  14. Jarow, 1990, Anabolic steroid–induced hypogonadotropic hypogonadism, Am J Sports Med, 18, 429, 10.1177/036354659001800417 · DOI
  15. Coward, 2013, Anabolic steroid–induced hypogonadism in young men, J Urol, 190, 2200, 10.1016/j.juro.2013.06.010 · DOI
  16. Cohen, 2007, A league of their own: demographics, motivations and patterns of use of 1,955 male adult nonmedical anabolic steroid users in the United States, J Int Soc Sports Nutr, 4, 12, 10.1186/1550-2783-4-12 · DOI · Paper page
  17. Bauermeister, 2012, Innovative recruitment using online networks: lessons learned from an online study of alcohol and other drug use utilizing a web-based, respondent-driven sampling (webRDS) strategy, J Stud Alcohol Drugs, 73, 834, 10.15288/jsad.2012.73.834 · DOI · Paper page
  18. Evans, 1997, Gym and tonic: a profile of 100 male steroid users, Br J Sports Med, 31, 54, 10.1136/bjsm.31.1.54 · DOI · Paper page
  19. Hildebrandt, 2006, Predicting intentions for long-term anabolic-androgenic steroid use among men: a covariance structure model, Psychol Addict Behav, 20, 234, 10.1037/0893-164X.20.3.234 · DOI
  20. Ip, 2011, The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training, Pharmacotherapy, 31, 757, 10.1592/phco.31.8.757 · DOI
  21. McCabe, 2004, Comparison of web and mail surveys in collecting illicit drug use data: a randomized experiment, J Drug Educ, 34, 61, 10.2190/4HEY-VWXL-DVR3-HAKV · DOI
  22. McCabe, 2005, Mode effects for collecting alcohol and tobacco data among 3rd and 4th grade students: a randomized pilot study of Web-form versus paper-form surveys, Addict Behav, 30, 663, 10.1016/j.addbeh.2004.08.012 · DOI
  23. Miller, 2010, Using the Internet to research hidden populations of illicit drug users: a review, Addiction, 105, 1557, 10.1111/j.1360-0443.2010.02992.x · DOI · Paper page
  24. Perry, 1992, Dying to be big: a review of anabolic steroid use, Br J Sports Med, 26, 259, 10.1136/bjsm.26.4.259 · DOI
  25. Young, 2012, Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use, J Addict Dis, 31, 332, 10.1080/10550887.2012.735564 · DOI
  26. Sjöqvist, 2008, Use of doping agents, particularly anabolic steroids, in sports and society, Lancet, 371, 1872, 10.1016/S0140-6736(08)60801-6 · DOI · Paper page
  27. de Souza, 2011, Anabolic steroids and male infertility: a comprehensive review, BJU Int, 108, 1860, 10.1111/j.1464-410X.2011.10131.x · DOI · Paper page
  28. Kanayama, 2009, Anabolic-androgenic steroid dependence: an emerging disorder, Addiction, 104, 1966, 10.1111/j.1360-0443.2009.02734.x · DOI · Paper page
  29. Perry, 2005, Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization, Clin J Sport Med, 15, 326, 10.1097/01.jsm.0000180872.22426.bb · DOI
  30. Pirola, 2010, Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism, Fertil Steril, 94, 2331.e1, 10.1016/j.fertnstert.2010.03.042 · DOI
  31. Cooper, 2013, In vitro androgen bioassays as a detection method for designer androgens, Sensors, 13, 2148, 10.3390/s130202148 · DOI
  32. Cordaro, 2011, Selling androgenic anabolic steroids by the pound: identification and analysis of popular websites on the Internet, Scand J Med Sci Sports, 21, e247, 10.1111/j.1600-0838.2010.01263.x · DOI
  33. Baume, 2006, Research of stimulants and anabolic steroids in dietary supplements, Scand J Med Sci Sports, 16, 41, 10.1111/j.1600-0838.2005.00442.x · DOI
  34. Cavalcanti Gd, 2013, Detection of designer steroid methylstenbolone in “nutritional supplement” using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites, Steroids, 78, 228, 10.1016/j.steroids.2012.11.009 · DOI
  35. Parr, 2007, High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market, Biomed Chromatogr, 21, 164, 10.1002/bmc.728 · DOI
  36. Vilella, 2013, Cholestatic jaundice as a result of combination designer supplement ingestion, Ann Pharmacother, 47, e33, 10.1345/aph.1R405 · DOI
  37. Cohen, 2012, Assessing supplement safety—the FDA's controversial proposal, N Engl J Med, 366, 389, 10.1056/NEJMp1113325 · DOI
  38. Pope, 2004, Anabolic steroid users' attitudes toward physicians, Addiction, 99, 1189, 10.1111/j.1360-0443.2004.00781.x · DOI · Paper page
  39. Kanayama, 2012, Illicit use of androgens and other hormones: recent advances, Curr Opin Endocrinol Diabetes Obes, 19, 211, 10.1097/MED.0b013e3283524008 · DOI
  40. Tan, 2009, Anabolic steroid-induced hypogonadism—toward a unified hypothesis of anabolic steroid action, Med Hypotheses, 72, 723, 10.1016/j.mehy.2008.12.042 · DOI
  41. Boregowda, 2011, Persistent primary hypogonadism associated with anabolic steroid abuse, Fertil Steril, 96, e7, 10.1016/j.fertnstert.2011.04.029 · DOI
  42. Kanayama, 2009, Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence, Am J Psychiatry, 166, 642, 10.1176/appi.ajp.2009.08111699 · DOI
  43. Evans, 2004, Current concepts in anabolic-androgenic steroids, Am J Sports Med, 32, 534, 10.1177/0363546503262202 · DOI · Paper page
  44. Maravelias, 2005, Adverse effects of anabolic steroids in athletes. A constant threat, Toxicol Lett, 158, 167, 10.1016/j.toxlet.2005.06.005 · DOI · Paper page
  45. Moretti, 2007, Structural sperm and aneuploidies studies in a case of spermatogenesis recovery after the use of androgenic anabolic steroids, J Assist Reprod Genet, 24, 195, 10.1007/s10815-005-9002-4 · doi:10.1007/s10815-005-9002-4
  46. Graham, 2008, Anabolic steroid use: patterns of use and detection of doping, Sports Med, 38, 505, 10.2165/00007256-200838060-00005 · DOI
  47. Arce, 1993, Exercise and male factor infertility, Sports Med, 15, 146, 10.2165/00007256-199315030-00002 · DOI
  48. Boettcher, 2011, Low-dose effects and biphasic effect profiles: is trenbolone a genotoxicant?, Mutat Res, 723, 152, 10.1016/j.mrgentox.2011.04.012 · DOI
  49. Chainy, 1997, Testosterone-induced changes in testicular antioxidant system, Andrologia, 29, 343, 10.1111/j.1439-0272.1997.tb00328.x · DOI · Paper page
  50. Karila, 2004, Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes, Int J Sports Med, 25, 257, 10.1055/s-2004-819936 · DOI
  51. Shokri, 2010, Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells, Basic Clin Pharmacol Toxicol, 106, 324, 10.1111/j.1742-7843.2009.00495.x · DOI
  52. Harkness, 1975, Effects of large doses of anabolic steroids, Br J Sports Med, 9, 70, 10.1136/bjsm.9.2.70 · doi:10.1136/bjsm.9.2.70
  53. Braunstein, 1999, Aromatase and gynecomastia, Endocr Relat Cancer, 6, 315, 10.1677/erc.0.0060315 · DOI · Paper page
  54. LeRoith, 1980, The effect of clomiphene citrate on pubertal gynaecomastia, Acta Endocrinol (Copenh), 95, 177
  55. Plourde, 1983, Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies, Am J Dis Child, 137, 1080, 10.1001/archpedi.1983.02140370040013 · DOI
  56. Serels, 1998, Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation, J Urol, 159, 1309, 10.1016/S0022-5347(01)63595-X · DOI
  57. Stepanas, 1977, Clomiphene in the treatment of pubertal-adolescent gynecomastia: a preliminary report, J Pediatr, 90, 651, 10.1016/S0022-3476(77)80394-6 · DOI
  58. Bickelman, 1995, Impotence related to anabolic steroid use in a body builder. Response to clomiphene citrate, West J Med, 162, 158
  59. Menon, 2003, Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin, Fertil Steril, 79, 1659, 10.1016/S0015-0282(03)00365-0 · DOI
  60. Tan, 2003, Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse, Fertil Steril, 79, 203, 10.1016/S0015-0282(02)04550-8 · DOI
  61. Weinstein, 1974, Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism, J Clin Invest, 53, 408, 10.1172/JCI107574 · DOI
  62. de Luis, 2001, An Med Interna, 18, 489
  63. Braunstein, 2007, Clinical practice. Gynecomastia, N Engl J Med, 357, 1229, 10.1056/NEJMcp070677 · DOI · Paper page
  64. Ferrando, 2002, Unilateral gynecomastia induced by treatment with 1 mg of oral finasteride, Arch Dermatol, 138, 543, 10.1001/archderm.138.4.533 · doi:10.1001/archderm.138.4.533
  65. Green, 1996, Gynecomastia and breast cancer during finasteride therapy, N Engl J Med, 335, 823, 10.1056/NEJM199609123351116 · DOI
  66. Lee, 2004, Male breast cancer during finasteride therapy, J Natl Cancer Inst, 96, 338, 10.1093/jnci/djh062 · DOI
  67. Traish, 2011, Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients, J Sex Med, 8, 872, 10.1111/j.1743-6109.2010.02157.x · DOI · Paper page
  68. Jameel, 2004, Gynaecomastia and the plant product “Tribulis terrestris”, Breast, 13, 428, 10.1016/j.breast.2003.10.013 · DOI
  69. Toorians, 2010, Gynaecomastia linked to the intake of a herbal supplement fortified with diethylstilbestrol, Food Addit Contam Part A Chem Anal Control, 27, 917, 10.1080/19440041003660869 · doi:10.1080/19440041003660869
  70. Deepinder, 2012, Drug-induced gynecomastia: an evidence-based review, Expert Opin Drug Saf, 11, 779, 10.1517/14740338.2012.712109 · DOI
  71. Dickson, 2012, Gynecomastia, Am Fam Physician, 85, 716
  72. Hanavadi, 2006, The role of tamoxifen in the management of gynaecomastia, Breast, 15, 276, 10.1016/j.breast.2005.04.007 · DOI
  73. Spano, 1984, Tamoxifen for gynecomastia induced by anabolic steroids?, N Engl J Med, 311, 861, 10.1056/NEJM198409273111323 · doi:10.1056/nejm198409273111323
  74. Babigian, 2001, Management of gynecomastia due to use of anabolic steroids in bodybuilders, Plast Reconstr Surg, 107, 240, 10.1097/00006534-200101000-00039 · doi:10.1097/00006534-200101000-00039
  75. Neild, 1995, Gynaecomastia in bodybuilders, Br J Clin Pract, 49, 172, 10.1111/j.1742-1241.1995.tb09941.x · doi:10.1111/j.1742-1241.1995.tb09941.x
  76. Lawrence, 2004, Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia, J Pediatr, 145, 71, 10.1016/j.jpeds.2004.03.057 · DOI
  77. Parker, 1986, Treatment of gynecomastia with tamoxifen: a double-blind crossover study, Metabolism, 35, 705, 10.1016/0026-0495(86)90237-4 · DOI
  78. Buvat, 1983, Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen, Fertil Steril, 39, 700, 10.1016/S0015-0282(16)47069-X · DOI
  79. de la Torre Abril, 2005, Arch Esp Urol, 58, 241
  80. Dony, 1985, Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men, Andrologia, 17, 369, 10.1111/j.1439-0272.1985.tb01024.x · DOI
  81. Tsourdi, 2009, The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia, Fertil Steril, 91, 1427, 10.1016/j.fertnstert.2008.06.002 · DOI
  82. Veldhuis, 1987, Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man, J Clin Invest, 80, 631, 10.1172/JCI113115 · DOI
  83. Vermeulen, 1978, Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men, Fertil Steril, 29, 320, 10.1016/S0015-0282(16)43160-2 · DOI
  84. Dohle, 2003, Androgens and male fertility, World J Urol, 21, 341, 10.1007/s00345-003-0365-9 · DOI · Paper page
  85. Lombardo, 2005, Androgens and fertility, J Endocrinol Invest, 28, 51
  86. Bagatell, 1996, Androgens in men—uses and abuses, N Engl J Med, 334, 707, 10.1056/NEJM199603143341107 · DOI · Paper page
  87. Ko, 2012, Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association, J Urol, 187, 973, 10.1016/j.juro.2011.10.137 · DOI · Paper page
  88. Basaria, 2010, Androgen abuse in athletes: detection and consequences, J Clin Endocrinol Metab, 95, 1533, 10.1210/jc.2009-1579 · DOI · Paper page
  89. Gazvani, 1997, Conservative management of azoospermia following steroid abuse, Hum Reprod, 12, 1706, 10.1093/humrep/12.8.1706 · DOI
  90. Knuth, 1989, Anabolic steroids and semen parameters in bodybuilders, Fertil Steril, 52, 1041, 10.1016/S0015-0282(16)53172-0 · DOI
  91. Turek, 1995, The reversibility of anabolic steroid-induced azoospermia, J Urol, 153, 1628, 10.1016/S0022-5347(01)67482-2 · DOI
  92. Grokett, 1992, The effects of an anabolic steroid (oxandrolone) on reproductive development in the male rat, Acta Endocrinol (Copenh), 126, 173
  93. Hsieh, 2013, Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy, J Urol, 189, 647, 10.1016/j.juro.2012.09.043 · DOI
  94. Kim, 2011, Penile growth in response to human chorionic gonadotropin (hCG) treatment in patients with idiopathic hypogonadotrophic hypogonadism, Chonnam Med J, 47, 39, 10.4068/cmj.2011.47.1.39 · DOI
  95. Gardner, 1968, The erythrocythaemic effects of androgen, Br J Haematol, 14, 611, 10.1111/j.1365-2141.1968.tb00367.x · DOI
  96. Gooren, 2010, Androgens and male aging: current evidence of safety and efficacy, Asian J Androl, 12, 136, 10.1038/aja.2010.4 · DOI
  97. Stergiopoulos, 2008, Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature, Vasc Health Risk Manag, 4, 1475, 10.2147/VHRM.S4261 · DOI

Cited by

See all 251

Metadata

Authors
Rahnema, C. D., Lipshultz, L. I., Crosnoe, L. E., Kovac, J. R., & Kim, E. D.
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2014-05
Volume
101
Issue
5
Pages
1271-1279
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2143638407
Cited by
251
References
11
FWCI
12.21
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.